Table 1.
Eligibility criteria | Exclusion criteria |
Histopathology confirmed | MRI examination contraindication |
Non-invasive diagnosis criteria [(EASL) 2012]1 | Significant renal insufficiency |
Cirrhotic patients | |
Hypervascular in the arterial phase | |
Washout in the portal venous or delayed phase | |
Non-antineoplaston therapy | Severe motion artifacts on MRI images |
The largest diameter of lesion ≥ 2 cm | Hepatic vein/portal cancer embolus |
Age of patients ≥ 18 yr | Inferior vena cava embolus |
Inability of informed written consent |
European Association for the Study of the Liver suggested non-invasive diagnosis criteria on 4-phase multidetector CT scan[13]. EASL: European Association for the Study of the Liver; MRI: Magnetic resonance imaging.